Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable company focused on
rolling-up annuity-based healthcare service companies in the US and Canada,
today appointed three highly qualified and experienced members to its newly
created Board of Advisors.


PHM is addressing a large and fragmented market of small, profitable businesses
providing healthcare products and services to chronically ill patients. PHM
plans to acquire these businesses and then offer additional services to its
entire patient base, thereby increasing revenue per patient and achieving
organic post acquisition growth.


Board of Advisors

Anticipating numerous further acquisitions in the near term, Bob Kusher, PHM's
CEO, has appointed several seasoned healthcare business veterans to a Board of
Advisors. The main task of this board is to offer advice and guidance to the
executive team on matters of acquisition integration and patient cross selling
strategies and tactics. 


PHM has initially appointed three professionals to the Board of Advisors:

Mark Kohler

Mr. Kohler is a chartered accountant in Canada and an expert in business
operations. He has extensive experience in US healthcare services and serves as
a member of the Board of Directors for QHR Technologies, Inc. (TSXV:QHR) 


Jim Booth

Mr. Booth is a seasoned senior executive with extensive experience in the home
health care marketplace. He recently retired from his position as CEO of Comfort
Keepers, a multinational provider of non-skilled home health services through
more than 600 franchised locations. Jim currently provides consulting services
both domestically in the US and internationally.


Dr. Stephen Axelrod, MD 

Dr. Axelrod built and directed a number of companies in the geriatric medicine
space, including SeniorMed, a specialized pharmacy company acquired by
Walgreen's. Stephen is CEO of a medication adherence company with clinical
program expertise in the US telehealth market.


PHM plans to issue 100,000 options to each member of the board, vesting over
three years. 


"Our post acquisition strategy is about revenue expansion," said Mr. Bob Kusher,
CEO of PHM. "We have built a nice pipeline of targets, even making a number of
offers which I am hopeful we can close. While ultimately we may not close any of
the companies we recently made offers to, I have confidence that we will be
closing acquisitions sooner than later. By acquiring businesses with core
competencies in specific service lines, along with their loyal patient base, we
can expand these services to all of our patients at PHM. The result is intended
to be significant revenue increases per patient after each acquisition. While it
does take time to integrate an acquisition and begin the process of offering
additional services to the existing patients, I believe this Advisory Board will
help us in that endeavor and, ultimately, make PHM more successful as a result."


About PHM

PHM is a profitable and cash flow positive company servicing patients with
chronic heart disease and will act as a platform for acquisitions. PHM is
focused on a highly fragmented and developing market of small privately-held
companies servicing chronically ill patients with multiple disease states caused
mainly by age and obesity. Because of the new and highly fragmented nature of
the market, PHM is actively working to identify and evaluate profitable,
annuity-based companies to acquire their patient databases and technical
expertise at favorable prices. PHM's post acquisition organic growth strategy is
to increase annual revenue per patient by offering multiple services to the same
patient, consolidating the patient's services and making life easier for the
patient. The expected result is growing EPS with each acquisition and growing
revenue and profits from the cross selling efforts. 


Forward-Looking Statements 

Information in this news release that is not current or historical factual
information may constitute forward-looking information within the meaning of
securities laws. Implicit in this information, particularly in respect of the
future outlook of PHM and anticipated events or results, are assumptions based
on beliefs of PHM's senior management as well as information currently available
to it. While these assumptions were considered reasonable by PHM at the time of
preparation, they may prove to be incorrect. 


Readers are cautioned that actual results are subject to a number of risks and
uncertainties, including the availability of funds and resources to pursue
operations or acquisitions, decline of reimbursement rates, dependence on few
payors, possible new drug discoveries, a novel business model, dependence on key
suppliers, granting of permits and licenses in a highly regulated business,
competition, availability of qualified senior management, risks from change in
ownership or unfamiliarity with new markets, low profit market segments as well
as general economic, market and business conditions, and could differ materially
from what is currently expected. 


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Michael Dalsin
Chairman
(323) 253-3055
Patient Home Monitoring Corp. (TSXV:PHM)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Patient Home Monitoring Corp. Charts.
Patient Home Monitoring Corp. (TSXV:PHM)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Patient Home Monitoring Corp. Charts.